Kidney Disease Market Poised to Hit $149.44 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Kidney Disease Market Size Growth Forecast: What to Expect by 2025?
The market size for kidney disease has seen significant expansion in the past few years. It is projected to expand from $107.29 billion in 2024 to $114.74 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth over the historic period includes the increase in chronic health issues, an aging demographic, susceptibility due to genetics, advancement in medical research and education, and environmental elements.

How Will the Kidney Disease Market Size Evolve and Grow by 2029?
The market size for kidney disease is projected to witness substantial expansion in the forthcoming years, reaching a value of $149.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The growth anticipated in this duration can be credited to the management of infectious diseases worldwide, the introduction of precision medicine techniques, the rise of diabetes and obesity, shifts in healthcare policies, and increased awareness and screening. Key trends to watch for in the forecast period comprise kidney care via telemedicine, emphasis on preventive nephrology, the surge in home-based dialysis, evolution of regenerative therapies, and alterations in diet and nutrition.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

What Drivers Are Propelling the Growth of Kidney Disease Market Forward?
The surge in kidney ailment cases is predicted to drive the expansion of the kidney disease market. Kidney diseases encompass a plethora of conditions that impinge on the kidneys' functionality and structure. Medications for kidney disorders administer functions such as reducing blood pressure in patients and minimizing protein loss. They consequently slow down kidney damage, manage symptoms, and prevent further complexities. For example, in June 2023, Kidney Research UK - a charitable organization based in the UK that focuses on research and advocacy for enhanced understanding, prevention, and treatment of kidney diseases - estimated that about 7.19 million people in the UK were suffering from chronic kidney disease. This represented more than 10% of the UK's population and is projected to rise to 7.61 million people by 2033. Hence, the escalating incidence of kidney ailments is spurring growth in the kidney disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

Which Emerging Trends Are Transforming the Kidney Disease Market in 2025?
The incorporation of tools powered by artificial intelligence (AI) is an evolving trend in the kidney disease market. Enterprises in this sector are leveraging cutting-edge technologies to enhance patient results and maintain their market prominence. For instance, an AI-focused healthcare startup based in the USA, Carenostics, introduced their pioneering product in November 2022. This product is designed to review electronic health record (EHR) data for the early detection of chronic kidney disease (CKD). Carenostics has adeptly incorporated AI-fueled clinical decision-support models into EHR systems utilized by healthcare providers. This integration assists healthcare practitioners in accurately identifying patients at high risk of chronic diseases, allowing them to take preemptive steps towards improved patient care.

What Are the Key Segments in the Kidney Disease Market?
The kidney disease market covered in this report is segmented -

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Who Are the Key Players Shaping the Kidney Disease Market's Competitive Landscape?
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

What Geographic Markets Are Powering Growth in the Kidney Disease Market?
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.